Firdapse for LEMS in Adults

February 13, 2019
Drew Boxler

Firdapse (amifampridine, Catalyst Pharmaceuticals)

Indications: treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

Dosage: 15 mg to 30 mg daily taken orally in divided doses (3 to 4 times daily); increased by 5mg daily every 3-4 days, not to exceed 80mg daily

Contraindications: History of seizures; hypersensitivity to amifampridine or another aminopyridine

Click here for more prescribing information

Related Content:

New Products